BIOMAT Database Logo BIOMAT Database Logo

Platelet fibrinogen binding in familial hypercholesterolemia. 1987

G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini

UI MeSH Term Description Entries
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic

Related Publications

G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia.
January 1986, Arteriosclerosis (Dallas, Tex.),
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia.
February 2001, The American journal of cardiology,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Increased Mean Platelet Volume in Familial Hypercholesterolemia.
February 2016, Angiology,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Increased platelet-fibrinogen interaction in patients with hypercholesterolemia and hypertriglyceridemia.
October 1993, Atherosclerosis,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Serum reserve cholesterol binding capacity (SRCBC) in familial hypercholesterolemia.
June 1982, Clinical genetics,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
The effect of human plasma on platelet function in familial hypercholesterolemia.
April 1982, Thrombosis research,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
[The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
July 1996, Casopis lekaru ceskych,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
[Familial hypercholesterolemia].
October 1982, Harefuah,
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
[Familial hypercholesterolemia].
November 2012, Deutsche medizinische Wochenschrift (1946),
G Di Minno, and A M Cerbone, and C Iride, and P L Mattioli, and A Postiglione, and M Mancini
Familial hypercholesterolemia.
December 1971, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!